American Shared Hospital Services adds Sandra Lawrence to its Board of Directors

– USA, CA – American Shared Hospital Services (NYSE:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that Sandra A.J. Lawrence has been appointed to the Company’s Board of Directors.

Sandra Lawrence is Chief Administrative Officer and Executive Vice President of The Children’s Mercy Hospitals and Clinics, Kansas City’s pediatric medical center and healthcare network, with responsibility for integrated care, network solutions and managed care operations, human resources, information systems, government relations, occupational health, and other critical operations. From 2005 to 2016, she was Chief Financial Officer and Executive Vice President of CMH and, prior to that, served on the hospital’s Governing Board and Foundation Board. Earlier, Lawrence worked at Midwest Research Institute, an independent laboratory that conducts scientific, applied research and technology development for defense, energy and life sciences, most recently serving as Chief Financial Officer and Senior Vice President.

Lawrence earned an MBA from Harvard Business School, a Master’s in Architecture from MIT, and an A.B. from Vassar College.

AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D. comments that, “Sandra Lawrence brings years of directly relevant experience in hospital management and operations, as well as expert knowledge of both government and private health insurance systems, to her new role on AMS’ Board of Directors. We welcome Sandra to AMS’ Board, and look forward to working closely with her in the years to come.”

Lawrence becomes the eighth member of AMS’s Board, and the sixth outside Director.

About AMS

American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Company also offers proton therapy, and the latest IGRT and IMRT systems. AMS owns a common stock investment in Mevion Medical Systems, Inc., developer of the compact MEVION S250 Proton Therapy System.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>